Niels Michael Dörr-Jerat

Dr. Niels Michael Dörr-Jerat

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2019 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
NDNiels Michael Dörr-Jerat
Niels Michael Dörr-Jerat
MBMichael Bartels
Michael Bartels
MMMehmet Haluk Morgul
Mehmet Haluk Morgul
Background/Aim: The treatment of colorectal liver metastases is challenging and requires multidisciplinary strategies. Unfortunately, only 25% of patients with colorectal liver metastases are eligible for liver resection. Due to the variety of therapeutic approaches, this percentage has increased; however, at the same time, the definition of resectability has become complex. The aim of this review was to provide an overview of current surgical therapies for colorectal liver metastases. Materials and Methods: Relevant studies published before June 2019 were identified using PubMed. A comprehensive review of the current literature regarding the impact of and innovations in the therapy of colorectal liver metastases was carried out. Results: The major advances in the resectability of colorectal liver metastases were effective chemotherapy regimens and preoperative liver volume modulation techniques. In addition, health professionals face rapid technical developments in interventional local therapies, minimally invasive surgery, robot-assisted surgery and even liver transplantation. Conclusion: Currently, liver metastases from colorectal cancer are considered a chronic disease. In cases of advanced colorectal liver metastases, the definition of resectability and the indications for surgical treatment should be exclusively determined by experienced hepatobiliary surgeons.

14 January 2020 in PLOS ONE
Verified
Journal Article
Open access
NDNiels Michael Dörr-Jerat
Niels Michael Dörr-Jerat
GDGunther Dietz
Gunther Dietz
Racism is a neglected but relevant cause of health disparities within multi-ethnic societies. Different types of racism and other expressions of discrimination must be recognized, critically analyzed, and actively reverted. This paper is based on anthropological fieldwork conducted in three medical facilities in the indigenous region Sierra de Totonacapan in the highlands of Veracruz in Mexico and analyzes maternal health and identifies levels of racism as perceived by female indigenous patients. Applying a theoretical framework that defines racism at three levels, namely, institutionalized, personally mediated, and internalized racism. We empirically distinguish and acknowledge human rights omissions and violations and then analyze the sources of racism in close relation to an intersectional view on gender, class-, and race-based forms of discrimination. Finally, in addition to investment in health goods and skilled birth attendants, we propose an intercultural competence approach to manage racism, among other ideologies. This approach targets health professionals as conscious, reflexive, and transformative actors of intercultural interactions with culturally diverse patients.

27 June 2024 in Frontiers in Surgery
Verified
Journal Article
Open access
PDF file
NDNiels Michael Dörr-Jerat
Niels Michael Dörr-Jerat
CMClaus May
Claus May
JKJürgen Knolle
Jürgen Knolle
SSSylke Schmidt
Sylke Schmidt
MKMarcus Krüger
Marcus Krüger
\D\R\Nniels Michael D
\R\Nniels Michael D
Introduction: We present the case of a patient with recurrent bilateral hemothorax. After misdiagnosis despite several histological samples, a pleural manifestation of epithelioid angiosarcoma was diagnosed by further immunohistological staining. Based on this situation, we aim to sensitize the reader to this rare disease.Main concerns and important clinical findings: A 73-year-old fully conscious woman presented with dyspnea for 3 days. She was in stable general condition, pain was denied, she had a history of cigarette smoking, she had no cardiopulmonary events, and she was not receiving any anticoagulation medication. Physical examination revealed decreased breath sounds on the left side, and her hemoglobin level was 7.0 mmol/L.Primary diagnoses, interventions, and outcomes: The initial chest x-ray showed a left-sided effusion. Hemothorax was then diagnosed. Further investigation revealed no evidence of malignancy (CT, EBUS, cytology, etc.). VATS was performed, and biopsies of pleural lesions did not reveal congruent findings for the hemothorax. Due to recurrent bilateral hemothorax with the need for erythrocyte transfusion, the patient underwent several operations, including histological sampling, without evidence of malignancy. After further processing, an additional pathological report revealed an epithelioid angiosarcoma defined by massively proliferating epithelioid cells strongly positive for ERG and CD31 and negative for CD34. The neoplastic cells coexpressed D2-40 (podoplanin). Finally, due to multiple cerebral metastases, palliative therapy was indicated.Conclusion: Physicians and pathologists treating spontaneous hemothorax need to have broad knowledge of the possible, sometimes rare, etiologies. If the clinical course and intraoperative findings do not agree with the histopathological results, this finding must be questioned, and further immunohistochemical staining is mandatory. Thus, in the case of recurrent hemothorax, angiosarcoma of the pleura should also be considered for differential diagnosis.

13 March 2024 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
NDNiels Michael Dörr-Jerat
Niels Michael Dörr-Jerat
MKMarcus Krüger
Marcus Krüger
MMMiriam Möller
Miriam Möller
NZNorman Zinne
Norman Zinne
MTMario Toennies
Mario Toennies
CBChristian Biancosino
Christian Biancosino
OBJECTIVES: Solitary fibrous tumours of the pleura (SFTP) are historically considered to be benign soft tissue neoplasms. However, a clinical relevant number of these neoplasms have malignant histological features. The objective of this study was to evaluate the percentage of SFTP presenting unfavourable clinical behaviour in order to predict negative long-term outcome.METHODS: A retrospective review of 74 patients treated at 4 hospitals between 1990 and 2013 was performed. The median follow-up was 10 years (range: 1–20 years). Risk of tumour recurrence and metastases (unfavourable clinical behaviour) with regard to histology using the Kaplan–Meier and Cox proportional hazards methods.RESULTS: The mean age was 61 years (SD 12.75 years). There were 31 male patients (58%) and 43 female patients (42%). Tumour size ranged from 1 to 30 cm (mean 9.09 cm; SD 6.22 cm). Complete resection (R0) was achieved by minimally invasive thoracoscopic resection in 29% and thoracotomy in 57%; 25% of SFTPs showed histological evidence of malignancy, according to England criteria. Recurrence occurred in 21% and 10% of patients had metastases; 83% of patients with metastases and 39% of patients with recurrence died within 5 years. The median recurrence-free survival for histologically benign SFTP was not reached, compared to 8 years for malignant SFTP. The five-year overall survival rate was 84%. Mitotic rate ≥1/10 HPF, high cellularity, nuclear atypia, Ki-67 level >5% and poorly circumscribed (sessile) growth pattern were associated with poor long-term outcome.CONCLUSIONS: Pathological differentiation of SFTP morphology into pedunculated, well circumscribed and poorly circumscribed (sessile) growth pattern is recommended. Due to the misleading classification into histologically benign and malignant, all unpedunculated SFTP should be classified as potentially aggressive. Lifelong follow-up is mandatory.

1 February 2021 in Social Medicine
Verified
Journal Article
Open access
PDF file
NDNiels Michael Dörr-Jerat
Niels Michael Dörr-Jerat
Maternal health is a complex issue. In Mexico, especially the population living in poverty and indigenous peoples are affected by health disparities, in particular, demonstrated by skilled birth attendance. The determinants mentioned by health professionals, especially structural barriers, characterize their perception. However, there are other barriers. The concept of intercultural medicine is understood as the adaptation of medical care to local reality to overcome cultural barriers. This article will conclude with a perspective that focuses on the possibilities and limitations of intercultural medicine for maternal health.

6 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
NDNiels Michael Dörr-Jerat
Niels Michael Dörr-Jerat
IWIna Wellmann
Ina Wellmann
FRFranziska Rees
Franziska Rees
MKMarcus Krüger
Marcus Krüger
HKHiltraud Kajüter
Hiltraud Kajüter
ASAndreas Stang
Andreas Stang
Background/Objectives: Angiosarcoma of the thorax is a very rare and malignant disease. We studied the incidence and survival of thoracic angiosarcomas with special focus on primary and secondary angiosarcoma. Methods: We analyzed data from the population-based cancer registry North Rhine-Westphalia (NRW), Germany, of the years 2008–2023. We included primary and secondary angiosarcoma of the thorax (ICD-O-3: morphology 9120/3, topography C34, C38, C44.51, C49.3, C50) and report age-standardized (Old European Standard population) incidence rates and survival (Kaplan-Meier Curves). Results: We analyzed 421 cases of thoracic angiosarcoma. 90.0% were female (n = 379). The age-standardized incidence rates of angiosarcoma of the thorax were 0.25 per million and year for male patients (SE 0.0) and 1.5 per million and year for female patients (SE 0.1). All male patients had primary angiosarcoma (n = 42). The majority of thoracic angiosarcoma among females were second primary tumors (n=262, 69.1%). The 5-year overall survival (OS) was 38.5% (SE 2.6). OS for women was 41.4% (SE 2.8) and for men was 12.0% (SE 5.4). OS for female patients was 40.9% (SE 4.1) and 41.8% (SE 3.8) for primary and second primary angiosarcoma respectively. The worst OS had patients with angiosarcoma of the lung (men 20.0% (SE 12.7) and mediastinum, heart and pleura (men 4.7% (SE 4.5). The OS for women was 0%, all females died within 2.2 years after diagnosis of angiosarcoma with these topographies. Conclusions: Angiosarcoma of the thorax is a rare condition with poor prognosis. Irrespective of the classification into primary and second primary, women with angiosarcoma have a better prognosis than men. Topography seems to be the most determining prognostic factor in this disease.